Raymond James Financial
ZYME icon

Raymond James Financial’s Zymeworks ZYME Stock Holding History

Raymond James Financial’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35M Sell
166,416
-9,995
-6% -$254K ﹤0.01% 2850
2026
Q1 		$4.42M Sell
176,411
-11,274
-6% -$267K ﹤0.01% 2695
2025
Q4 		$4.94M Buy
187,685
+64,817
+53% +$1.41M ﹤0.01% 2522
2025
Q3 		$2.1M Sell
122,868
-1,567
-1% -$22.4K ﹤0.01% 3143
2025
Q2 		$1.56M Buy
124,435
+7,724
+7% +$92K ﹤0.01% 3279
2025
Q1 		$1.39M Buy
116,711
+56,069
+92% +$765K ﹤0.01% 3252
2024
Q4 		$888K Buy
+60,642
New +$848K ﹤0.01% 3531

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Raymond James Financial's ZYME Position: Q2 2026 in Review

Raymond James Financial reduced its Zymeworks (ZYME) stake by 5.7% in Q2 2026, selling an estimated $254K and leaving 166,416 shares worth $4.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

Raymond James Financial first reported a position in ZYME in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.94M in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Raymond James Financial held 166,416 shares of Zymeworks worth $4.35M as of Q2 2026.
  • Raymond James Financial sold 9,995 Zymeworks shares in Q2 2026, an estimated $254K.
  • Zymeworks made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2850 holding.
  • Raymond James Financial first reported a position in Zymeworks in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Zymeworks position peaked at $4.94M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.